Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT
  Hypertriglyceridaemia Secondary to Liver Disease

Müller, P., Fellin, R., Lambrecht, J., Agostini, B., Wieland, H., Rost, W., et al. (1974). Hypertriglyceridaemia Secondary to Liver Disease. European Journal of Clinical Investigation, 4(6), 419-428. doi:10.1111/j.1365-2362.1974.tb02357.x.

Item is

Externe Referenzen

einblenden:
ausblenden:
externe Referenz:
https://doi.org/10.1111/j.1365-2362.1974.tb02357.x (beliebiger Volltext)
Beschreibung:
-
OA-Status:

Urheber

einblenden:
ausblenden:
 Urheber:
Müller, P.1, Autor           
Fellin, R., Autor
Lambrecht, J., Autor
Agostini, Bruno2, Autor           
Wieland, Heike3, Autor           
Rost, W., Autor
Seidel, D.4, Autor           
Affiliations:
1Department of Molecular Developmental Biology, MPI for biophysical chemistry, Max Planck Society, ou_578590              
2Department of Biomedical Optics, Max Planck Institute for Medical Research, Max Planck Society, ou_1497699              
3Department of Molecular Neurobiology, Max Planck Institute for Medical Research, Max Planck Society, ou_1497704              
4Max Planck Institute for Medical Research, Max Planck Society, ou_1125545              

Inhalt

einblenden:
ausblenden:
Schlagwörter: -
 Zusammenfassung: Abstract. Some patients with liver dysfunction show a marked hypertriglyceridaemia, a phenomenon most frequently accompanied by cholestasis. In this report we have identified, isolated and characterized an abnormally large (300–700 Å), triglyceride rich, low density lipoprotein, (d 1.019-1.063 g/ml) designated β-lipoprotein (β2-LP), from the plasma of patients with hypertriglyceridaemia secondary to liver disease. The βa-LP differs significantly in its percent composition and protein moiety from the unique lipoprotein-X (LP-X) specific for cholestasis and also from normal β-lipoproteins, both of which are also present in the patients LDL fraction. Furthermore, some evidence is provided suggesting that the β2-LP is likely to represent an intermediate particle of chylomicron metabolism, which accumulates in this disease due to a markedly diminished hepatic lipase activity.

Details

einblenden:
ausblenden:
Sprache(n): eng - English
 Datum: 1974-12
 Publikationsstatus: Erschienen
 Seiten: 10
 Ort, Verlag, Ausgabe: -
 Inhaltsverzeichnis: -
 Art der Begutachtung: Expertenbegutachtung
 Identifikatoren: DOI: 10.1111/j.1365-2362.1974.tb02357.x
 Art des Abschluß: -

Veranstaltung

einblenden:

Entscheidung

einblenden:

Projektinformation

einblenden:

Quelle 1

einblenden:
ausblenden:
Titel: European Journal of Clinical Investigation
Genre der Quelle: Zeitschrift
 Urheber:
Affiliations:
Ort, Verlag, Ausgabe: Oxford : Blackwell Scientific Publ. [etc.]
Seiten: - Band / Heft: 4 (6) Artikelnummer: - Start- / Endseite: 419 - 428 Identifikator: ISSN: 0014-2972
CoNE: https://pure.mpg.de/cone/journals/resource/954925398486